Laurion Capital Management’s Icosavax, Inc. Common Stock ICVX Stock Holding History

Laurion Capital Management’s Portfolio ICVX Stock Details ICVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-952,060	Closed	-$15M	–	661
2023 Q4	$15M	Buy	952,060 +209,706	+28%	+$2.02M	0.13%	147
2023 Q3	$5.75M	Hold	742,354	–	–	0.04%	268
2023 Q2	$7.37M	Hold	742,354	–	–	0.04%	237
2023 Q1	$4.31M	Hold	742,354	–	–	0.03%	244
2022 Q4	$5.89M	Hold	742,354	–	–	0.03%	257
2022 Q3	$2.35M	Hold	742,354	–	–	0.01%	317
2022 Q2	$4.25M	Hold	742,354	–	–	0.07%	180
2022 Q1	$5.23M	Sell	742,354 -7,646	-1%	-$120K	0.06%	160
2021 Q4	$17.2M	Hold	750,000	–	–	0.17%	93
2021 Q3	$22.2M	Buy	+750,000	New	+$25.4M	0.09%	193

Laurion Capital Management's ICVX Position: Q1 2024 in Review

Laurion Capital Management sold out of Icosavax, Inc. Common Stock (ICVX) in Q1 2024, closing a stake of 952,060 shares — an estimated $15M sold.

Laurion Capital Management first reported a position in ICVX in Q3 2021 and held it in 10 quarters. The position peaked at $22.2M in Q3 2021. 0 funds tracked by Wall St. Rank hold ICVX as of Q1 2024.

Laurion Capital Management reported no remaining Icosavax, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Laurion Capital Management sold 952,060 Icosavax, Inc. Common Stock shares in Q1 2024, an estimated $15M.
Laurion Capital Management first reported a position in Icosavax, Inc. Common Stock in Q3 2021 and held it in 10 quarters.
Laurion Capital Management's Icosavax, Inc. Common Stock position peaked at $22.2M in Q3 2021.
0 funds tracked by Wall St. Rank held Icosavax, Inc. Common Stock as of Q1 2024.

Based on Laurion Capital Management's 13F filing for Q1 2024, filed 15 May 2024.